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Reduced Rate of Hospital Admissions for ACS 
during Covid-19 Outbreak in Northern Italy
To the Editor: To address the coronavirus 
(Covid-19) pandemic,1 strict social containment 
measures have been adopted worldwide, and health 
care systems have been reorganized to cope with 
the enormous increase in the numbers of acute-
ly ill patients.2,3 During this same period, some 
changes in the pattern of hospital admissions 
for other conditions have been noted. The aim of 
the present analysis is to investigate the rate of 
hospital admissions for acute coronary syndrome 
(ACS) during the early days of the Covid-19 
outbreak.
In this study, we performed a retrospective 
analysis of clinical and angiographic character-
istics of consecutive patients who were admitted 
for ACS at 15 hospitals in northern Italy. All the 
hospitals were hubs of local networks for treat-
ment involving primary percutaneous coronary 
intervention. The study period was defined as the 
time between the first confirmed case of Covid-19 
in Italy (February 20, 2020) and March 31, 2020. 
We compared hospitalization rates between the 
study period and two control periods: a corre-
sponding period during the previous year (Feb-
ruary 20 to March 31, 2019) and an earlier pe-
riod during the same year (January 1 to February 
19, 2020). The primary outcome was the overall 
rate of hospital admissions for ACS. We calcu-
lated incidence rates for the primary outcome by 
dividing the number of cumulative admissions 
Table 1. Comparison of Hospital Admissions for Acute Coronary Syndrome (ACS) in Northern Italy between the Onset 










All ACS  2202
No. of daily admissions 13.3 18.0 18.9
Incidence rate ratio (95% CI) 0.74 (0.66–0.82) 0.70 (0.63–0.78)
P value <0.001 <0.001
STEMI 957
No. of daily admissions 6.1 7.8 8.0
Incidence rate ratio (95% CI) 0.77 (0.66–0.91) 0.75 (0.64–0.89)
NSTEMI 832
No. of daily admissions 4.2 7.1 7.5
Incidence rate ratio (95% CI) 0.59 (0.49–0.71) 0.56 (0.46- 0.67)
Unstable angina 413
No. of daily admissions 3.1 3.1 3.4
Incidence rate ratio (95% CI) 1.00 (0.79–1.26) 0.91 (0.72–1.16)
*  The study period was defined as the time between the first confirmed case of Covid-19 in Italy (February 20, 2020) and 
March 31, 2020. The two control periods were from January 1 to February 19, 2020 (same year) and from February 20 
to March 31, 2019 (previous year). The 95% confidence intervals are not adjusted for multiple testing and therefore 
should not be used to infer definitive effects. CI denotes confidence interval, NSTEMI non–ST-segment elevation myo-
cardial infarction, and STEMI ST-segment elevation myocardial infarction.
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by the number of days for each time period. In-
cidence rate ratios comparing the study period 
with each of the control periods were calculated 
with the use of Poisson regression. (Details re-
garding the study methods are provided in the 
Supplementary Appendix, available with the full 
text of this letter at NEJM.org.)
Of the 547 patients who were hospitalized for 
ACS during the study period, 420 (76.8%) were 
males; the mean (±SD) age was 68±12 years. Of 
these patients, 248 (45.3%) presented with ST-
segment elevation myocardial infarction (STEMI). 
The mean admission rate for ACS during the 
study period was 13.3 admissions per day. This 
rate was significantly lower than either the rate 
during the earlier period in the same year (total 
number of admissions, 899; 18.0 admissions per 
day; incidence rate ratio, 0.74; 95% confidence 
interval [CI], 0.66 to 0.82; P<0.001) or the rate 
during the previous year (total number of admis-
sions, 756; 18.9 admissions per day; incidence 
rate ratio, 0.70; 95% CI, 0.63 to 0.78; P<0.001). 
The incidence rate ratios for individual ACS sub-
types are presented in Table 1. After the national 
lockdown was implemented on March 8, 2020,4 a 
further reduction in ACS admissions was report-
ed. (Details regarding the full secondary analyses 
are provided in the Supplementary Appendix.)
This report shows a significant decrease in 
ACS-related hospitalization rates across several 
cardiovascular centers in northern Italy during 
the early days of the Covid-19 outbreak. Recent 
data suggest a significant increase in mortality 
during this period that was not fully explained 
by Covid-19 cases alone.5 This observation and 
data from our study raise the question of whether 
some patients have died from ACS without seek-
ing medical attention during the Covid-19 pan-
demic.
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